<code id='80788C0747'></code><style id='80788C0747'></style>
    • <acronym id='80788C0747'></acronym>
      <center id='80788C0747'><center id='80788C0747'><tfoot id='80788C0747'></tfoot></center><abbr id='80788C0747'><dir id='80788C0747'><tfoot id='80788C0747'></tfoot><noframes id='80788C0747'>

    • <optgroup id='80788C0747'><strike id='80788C0747'><sup id='80788C0747'></sup></strike><code id='80788C0747'></code></optgroup>
        1. <b id='80788C0747'><label id='80788C0747'><select id='80788C0747'><dt id='80788C0747'><span id='80788C0747'></span></dt></select></label></b><u id='80788C0747'></u>
          <i id='80788C0747'><strike id='80788C0747'><tt id='80788C0747'><pre id='80788C0747'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:33
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug
          ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

          ADAMFEUERSTEIN/STATCHICAGO—CorbusPharmaceuticalsisthesecondbest-performingbiotechstockthisyear,thank

          read more
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more

          For one rare type of lung cancer, Pfizer pill reduces progression by 81%

          AP/BusinessWireTherearealotofreasonswhyupdateddataonPfizer’sLorbrena,atreatmentfornon-smallcelllungc